Adenosine triphosphate - Established and potential clinical applications

被引:173
作者
Agteresch, HJ
Dagnelie, PC
van den Berg, JWO
Wilson, JHP
机构
[1] Maastricht Univ, Dept Epidemiol, NL-6200 MD Maastricht, Netherlands
[2] Erasmus Univ, Dept Internal Med 2, Rotterdam, Netherlands
关键词
D O I
10.2165/00003495-199958020-00002
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Adenosine 5'-triphosphate (ATP) is a purine nucleotide found in every cell of the human body. In addition to its well established role in cellular metabolism, extracellular ATP and its breakdown product adenosine, exert pronounced effects in a variety of biological processes including neurotransmission, muscle contraction, cardiac function, platelet function, vasodilatation and liver glycogen metabolism. These effects are mediated by both P1 and P2 receptors. A cascade of ectonucleotidases plays a role in the effective regulation of these processes and may also have a protective function by keeping extracellular ATP and adenosine levels within physiological limits. In recent years several clinical applications of ATP and adenosine have been reported. In anaesthesia, low dose adenosine reduced neuropathic pain, hyperalgesia and ischaemic pain to a similar degree as morphine or ketamine. Postoperative opioid use was reduced. During surgery, ATP and adenosine have been used to induce hypotension. In patients with haemorrhagic shock, increased survival was observed after ATP treatment. In cardiology, ATP has been shown to be a well tolerated and effective pulmonary vasodilator in patients with pulmonary hypertension. Bolus injections of ATP and adenosine are useful in the diagnosis and treatment of paroxysmal supraventricular tachycardias. Adenosine also allowed highly accurate diagnosis of coronary artery disease. In pulmonology, nucleotides in combination with a sodium channel blocker improved mucociliary clearance from the airways to near normal in patients with cystic fibrosis. In oncology, there are indications that ATP may inhibit weight loss and tumour growth in patients with advanced lung cancer. There are also indications of potentiating effects of cytostatics and protective effects against radiation tissue damage. Further controlled clinical trials are warranted to determine the full beneficial potential of ATP, adenosine and uridine 5'-triphosphate.
引用
收藏
页码:211 / 232
页数:22
相关论文
共 315 条
  • [1] PURINOCEPTORS - ARE THERE FAMILIES OF P2X AND P2Y PURINOCEPTORS
    ABBRACCHIO, MP
    BURNSTOCK, G
    [J]. PHARMACOLOGY & THERAPEUTICS, 1994, 64 (03) : 445 - 475
  • [2] Cystic fibrosis hetero- and homozygosity is associated with inhibition of breast cancer growth
    Abraham, EH
    Vos, P
    Kahn, J
    Grubman, SA
    Jefferson, DM
    Ding, I
    Okunieff, P
    [J]. NATURE MEDICINE, 1996, 2 (05) : 593 - 596
  • [3] Cystic fibrosis transmembrane conductance regulator and adenosine triphosphate
    Abraham, EH
    Okunieff, P
    Scala, S
    Vos, P
    Oosterveld, MJS
    Chen, AY
    Shrivastav, B
    Guidotti, G
    [J]. SCIENCE, 1997, 275 (5304) : 1324 - 1325
  • [4] Alves LA, 1996, BLOOD, V88, P328
  • [5] Identification of severe or extensive coronary artery disease in women by Adenosine technetium-99m sestamibi SPECT
    Amanullah, AM
    Berman, DS
    Hachamovitch, R
    Kiat, H
    Kang, XP
    Friedman, JD
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1997, 80 (02) : 132 - 137
  • [6] INHIBITION OF GLUCONEOGENESIS BY EXTRACELLULAR ATP IN ISOLATED RAT HEPATOCYTES
    ASENSI, M
    LOPEZRODAS, A
    SASTRE, J
    VINA, J
    ESTRELA, JM
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1991, 261 (06): : R1522 - R1526
  • [7] INTRAOPERATIVE BLOOD-PRESSURE CONTROL BY ATP IN PHEOCHROMOCYTOMA
    ASO, Y
    TAJIMA, A
    SUZUKI, K
    OHMI, Y
    KANBAYASHI, T
    MITSUHASHI, T
    IKEDA, K
    [J]. UROLOGY, 1986, 27 (06) : 512 - 520
  • [8] AVERY RK, 1992, J IMMUNOL, V149, P1265
  • [9] SELECTIVE ENHANCEMENT OF INTRATUMORAL BLOOD-FLOW IN MALIGNANT GLIOMAS USING INTRAARTERIAL ADENOSINE-TRIPHOSPHATE
    BABA, T
    FUKUI, M
    TAKESHITA, I
    ICHIYA, Y
    KUWABARA, Y
    HASUO, K
    [J]. JOURNAL OF NEUROSURGERY, 1990, 72 (06) : 907 - 911
  • [10] BARANKIEWICZ J, 1988, J BIOL CHEM, V263, P7094